CytoSorbents Corporation (CTSO)

[ping_pow_princess]

The reason for the cash raising is stated in the PR: "The company intends to use the net proceeds from this offering for general corporate and working capital purposes, including advancing its U.S. pivotal trial for treatment of inflammation in conjunction with cardiac surgery."

The results of REFRESH I will be the next PR. Following that, a PR that the FDA approved their advancement of the US pivotal trial since it was been mentioned in the follow up offering PR.